SalutarisMD receives FDA clearance for radionuclide brachytherapy source

BARCELONA — Salutaris Medical Devices has received 510(k) clearance from FDA for its SMD Sr90-1 radionuclide brachytherapy source, according to a press release.The treatment is indicated for episcleral brachytherapy of tumors and benign growths for use within a manual brachytherapy applicator system, the release said.